Dr. Dan Stickler
speaker
120 appearances
1 recordings
1 series
first heard Nov 2024
last heard Nov 2024
Dr. Dan Stickler’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
A lot of people ask me, you know, is AI going to replace physicians? And the answer is yes, if physicians don't change their mindset a little bit, because the majority of physicians using AI use them as research assistants. They're not interacting with the AI. Evidence-based medicine has been valuable, but it's also reductionistic and
you can't treat a human in a reductionistic way because we're a complex adaptive system and psychedelic experience helped to open up possibilities for me because i started looking at things and i was saying well what if instead of like oh there is no proof of that i've seen some stuff that has been very consistent
But we don't have the measuring tools because we don't know what frequency it is or what part of the electromagnetic spectrum is occurring. But you hear about these things. And so you say, well, what if? It's just like placebo effect. People talk about that like it's just placebo effect. And I'm like, are you kidding me? That's the coolest thing that I have seen in so long.
I mean, what is the magic of the placebo effect that it's so effective? I mean, when you look at brain mapping of people on psychedelics, there are massive amounts of interconnections being made. So the brain is communicating with areas that it normally doesn't communicate with. And it's looking for new pathways.
Well, thank you for that beautiful introduction. I mean, I'm used to people running through credentials and all of that, but I love that. That was perfect.
We try to delve into all of the leading edge types of therapies that are out there, even the ones... You have your evidence-based stuff, but you have stuff that you know you've seen work. Anecdotally, there's common sense behind it, and yet there's not the science to support it.
I think a lot of it is that we just don't have the available testing that can measure the responses that you get from it. I mean, just... A lot of stuff with like yoga and meditation. I mean, for years, everybody knew it worked. But how do you quantify that? And then comes along epigenetics.
And then we have scientific evidence that says, oh, okay, yes, we do have the scientific evidence that it works. And I think a lot of the modalities that we look into are the ones that are the meditation of 20 years ago prior to that. So we'll do a lot of work with that. We work with a lot of IRBs, so Institutional Review Board studies that are early access to IRBs.
Different forms of testing, different forms of intervention that we feel might be promising for moving forward. And so we'd like to really stay on that leading edge of the new and exciting therapies that are out there.
Like we've been doing a lot of apheresis, which is the removal of a liter of plasma.
Yeah, I mean, the plasma is carrying a bunch of proteins, exosomes, microRNAs, but they can also be carrying a lot of inflammatory things. This is like the email system of the body. So it's sending out all of these messages to inform other cells of what is happening in the environment. And basically, we live in a fairly toxic environment.
So it made a lot of stress responses in there. Session of apheresis removes about 40% of that plasma volume. And then we replace it with saline and albumin. And so that albumin has a bunch of clean binding sites on it to bind up toxins and other things. Items in the blood. And so it cleanses the blood essentially. We're involved in a study that's looking at it with aging.
We're working with some stuff with people that have Lyme, people that have long COVID. And we're seeing anecdotally really good responses from it. We can't say anything from a scientific standpoint quite yet because we don't have enough people involved to do that, but that's what part of this study is determining.
There have been some studies out of Stanford that showed positive effects on aging, cognitive decline in older people, but in some of the younger people we're also seeing, especially with long COVID, we're seeing really impressive results. That's one area we're also involved in a study that's using young plasma to replace the plasma that we remove.
This is really exciting because young plasma is plasma from donors that are between 18 and 24 years old. And this is where... Our human system is at its peak physiologic optimal performance at that age. That's our peak reproductive age. And so all of the things circulating in that plasma is really pro-life-giving at that point.
So we're taking older individuals, especially individuals with early dementia, and And we're replacing their plasma with this young plasma. We take off 40% and we give them one, two, or three liters of this young plasma. I mean, it's very impressive. And again, we can't say anything about it because it's a study in progress. And I just say anecdotally, it's pretty impressive right now.
Right. We do ketamine therapies in the clinic. Not so much from the psychotherapeutic standpoint. Most of our ketamine therapies are... designed around where people are waking up, and they're going through some existential crises. You know, what's it all mean? Why am I here? Is their purpose to any of this? And we can help guide them through that process with the ketamine therapies.
And that's been really rewarding.
So we take a systems-based approach and that has been the key differentiator for us in the outcomes that we see. We look at the human organism as a whole and not as these individual puzzle pieces that we have to put together. You know, the people that are experts in the heart, people that are experts in the liver, and that's what they focus on.
But that's not the way the human system actually exists. We are a whole system. And so when we approach things, we want to assess where the whole system is in this moment in time. So we collect as much data as we can on an individual basis. We're getting extensive amounts of blood work. We're getting QEEG brain maps. We're getting psychophysiologic stress profiles.
Showing 1–20 of 120 · page 1 of 6
Next →